南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

FBXO28可靶向SNAI1蛋白,介导其被泛素-蛋白酶体系统降解,从而参与非小细胞肺癌的发生发展过程。

FBXO28 targets SNAI1 for ubiquitin-proteasomal degradation in non-small cell lung cancer

Jingyu Lin, Xinran Qiao, Hua Liu, Yang Chen, Zhen Li, Xinyi Tong, Mi Shen, Rui Zhang, Ying Han, Jiajia Shen, Zhen Wang

Journal:JOURNAL OF BIOLOGICAL CHEMISTRY

IF:4.1

DOI:10.1016/j.jbc.2026.113405

PMID:

Published:2026-08-13

research field:分子生物学毒理学内分泌学生殖生物学环境健康

Abstract

SNAI1 is a central regulator of the epithelia-mesenchymal transition, which is highly instable and degraded through the ubiquitin-proteasome system. Although a panel of E3 ubiquitin ligases responsible for SNAI1 degradation have been discovered, whether there exists other E3 ubiquitin ligase remains unclarified. In this study, we demonstrate that FBXO28 expression is downregulated in non-small cell lung cancer (NSCLC) tissues compared to adjacent non-cancerous tissues, correlating with beneficial patient prognosis. Specifically, FBXO28 physically interacts with SNAI1, promoting its polyubiquitination and degradation in a mechanism dependent on phosphorylation by glycogen synthase kinase-3 β (GSK3 β ). Functional assays indicate that FBXO28 controls the half-life of SNAI1 protein, which are abrogated by proteasome inhibitor MG132 in NSCLC cells. Importantly, FBXO28 suppresses the migratory and invasive abilities of NSCLC cells, an effect that can be mitigated by GSK3 β inhibition. We also present data to show that SNAI1, along with SNAI2, mediates the regulatory function of FBXO28 towards migration and invasion of NSCLC cells in mice and zebrafish xenograft models. Collectively, our findings elucidate a significant role for FBXO28 in regulating SNAI1 stability via the ubiquitin-proteasome system, thereby providing insights into therapeutic strategies aimed at constraining metastasis in NSCLC.

本文使用的Yeasen产品

购物车
客服
转染试用